WallStreetZenWallStreetZen

NASDAQ: INDV
Indivior Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Indivior Pharmaceuticals earnings were $166.0M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest INDV earnings report on Sep 30, 2025 announced Q3 2025 earnings of $42.0M, up 133.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INDV reported annual earnings of $2.0M, with -101.6% growth. The next INDV earnings date is Feb 26, 2026.

INDV earnings history

Current Revenue
$1.2B
Current Earnings
$166.0M
Current Profit Margin
14.1%

INDV Return on Equity

Current Company
-61.1%
Current Industry
15%
Current Market
35.1%
INDV's Return on Equity (-69.6%)... subscribe to Premium to read more.
High Return on Equity Performance

INDV Return on Assets

Current Company
11.9%
Current Industry
5.6%
INDV is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INDV announces earnings.

INDV Return on Capital Employed

Current Company
65.63%
Current Industry
9.7%

INDV vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INDV$316.00M$166.00MN/A$1.31
AMRX$503.93M$5.90M-46.59%$0.02
LNTH$326.91M$167.68M+98.25%$2.45
PBH$346.27M$186.50M+2.85%$3.81
ALKS$436.54M$338.83M+26.67%$2.07
View Top Pharmaceutical Stocks

INDV earnings dates

Next earnings date
Feb 26, 2026

Indivior Pharmaceuticals Earnings Reports & History FAQ

What were Indivior Pharmaceuticals's earnings last quarter?

On INDV's earnings call on Invalid Date, Indivior Pharmaceuticals (NASDAQ: INDV) reported Q3 2025 earnings per share (EPS) of $0.34, up 112.5% year over year. Total INDV earnings for the quarter were $42.00 million. In the same quarter last year, Indivior Pharmaceuticals's earnings per share (EPS) was $0.16.

If you're new to stock investing, here's how to buy Indivior Pharmaceuticals stock.

When does Indivior Pharmaceuticals report earnings?

The next INDV earnings call is Invalid Date. Add INDV to your watchlist to be reminded of Indivior Pharmaceuticals's next earnings date.

Is Indivior Pharmaceuticals profitable or losing money?

As of the last Indivior Pharmaceuticals earnings report, Indivior Pharmaceuticals is currently profitable. Indivior Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $166.00 million, a 282.42% decrease year over year.

What was INDV's earnings growth in the past year?

As of Indivior Pharmaceuticals's earnings date in Invalid Date, Indivior Pharmaceuticals's earnings has grown year over year. INDV earnings in the past year totalled $166.00 million.

What are Indivior Pharmaceuticals's earnings expectations?

The current EPS estimate for Indivior Pharmaceuticals's earnings report in Invalid Date is $0.67.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.